|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Microfluidizer Á¾ÇÕÄ«´Ù·Î±× |
Phone |
|
|
  ´ëÇ¥ÀüÈ |
1577-7956   |
  º»     »ç |
031-457-9187   |
  ´ë     Àü |
042-932-1265 |
|
|
Web Site Visitors |
|
|
  Today |
520     |
  Yesterday |
637     |
  Since 2006 |
1,757,442     |
|
|
|
|
Microfluidics »ç´Â 9¿ù 22ÀÏ HDT ÀÇ ¼ö¼®¿¬±¸¿øÀÎ Dr. Darrick Carter ÀÇ ¿Â¶óÀÎ ¼¼¹Ì³ª¸¦ ´ÙÀ½°ú °°Àº ÁÖÁ¦·Î °³ÃÖÇÏ¿´½À´Ï´Ù.
- A Scalable Solution for the Creation of Lipid Nanoparticles for RNA Delivery.
Dr. Darrick Carter ´Â ÀÌ ¼¼¹Ì³ª¸¦ ÅëÇØ HDT Bio »ç°¡ °³¹ßÇÑ °·ÂÇÑ RNA Delivery System ÀÎ LION¢â Cationic Nanoemulsion À» ¼Ò°³ÇÏ¿´À¸¸ç
ÀÌ Delivery System ÀÇ °¡Àå Áß¿äÇÑ Æ¯Â¡Àº ´ÙÀ½°ú °°½À´Ï´Ù.
LION¢â Cationic Nanoemulsion
Very Stable
LION particle ¿¡ °áÇÕÇÑ RNA ´Â ÀÎü³»¿¡¼ ¸Å¿ì stable ÇÑ »óŸ¦ À¯ÁöÇÕ´Ï´Ù.
No RNA modification
LNP ¿¡ »ç¿ëµÇ´Â RNA ´Â ¼¼Æ÷³» °ø°ÝÀ» ¹æ¾îÇϱâ À§ÇØ methylated RNA ¸¦ »ç¿ëÇÏÁö¸¸
LION ¿¡ »ç¿ëµÇ´Â RNA ´Â ÀÌ·¯ÇÑ RNA modification ÀÌ ÇÊ¿ä¾ø½À´Ï´Ù.
Low Cost
RNA ¸¦ modification Çϴµ¥´Â ºñ¿ëÀÌ ¾öû³ª°Ô ºñ½Ô´Ï´Ù. ±×·¯¹Ç·Î RNA modification À» ÇÏÁö ¾Ê´Â LION¢â Cationic Nanoemulsion Àº
Á¦Á¶ ºñ¿ëÀÌ ¸Å¿ì Àú·ÅÇÕ´Ï´Ù.
Self Amplification
¼¼Æ÷³»¿¡ µé¾î°£ RNA ´Â self-replication À» ÇÏ¿© 30~50 ¹è ¸¹Àº RNA ·Î ÁõÆøÀ» ÇÏ°Ô µÇ¾î ´õ ¸¹Àº Ç׿ø ´Ü¹éÁúÀÌ
»ý¼ºµÇ¹Ç·Î ±âÁ¸ LNP ¹æ½Ä¿¡ ºñÇØ ÁßÈÇ×ü »ý¼ºÀÌ ¸Å¿ì È¿À²ÀûÀÔ´Ï´Ù.
Much Less Side Effects
LION¢â Cationic Nanoemulsion ¿¡´Â ÀÎü¿¡ ºÎÀÛ¿ëÀ» ÀÏÀ¸Å°´Â PEG °°Àº ¹°ÁúÀ» »ç¿ëÇÏÁö ¾Ê¾Æ
±âÁ¸ LNP ¹æ½Ä¿¡ ºñÇØ ÀÎü ºÎÀÛ¿ëÀÌ ¸Å¿ì Àû½À´Ï´Ù.
|
¡Ø ÀÌ È¸éÀ» click ÇϽøé Youtube µ¿¿µ»óÀ¸·Î À̵¿µË´Ï´Ù. |
ÀÌ ¹ßÇ¥´Â ´ÙÀ½°ú °°Àº ³»¿ëÀ¸·Î ÀÌ·ç¾î Á® ÀÖ½À´Ï´Ù.
- Overview of RNA from discovery to approval of an mRNA vaccine in 2020
- LNPs, CNEs and LION¢â - The limitations and advantages of major delivery systems   in use for RNA
- How self-amplifying RNAs work
- Vaccine results with LION¢â, a next generation RNA delivery system
- Future uses of mRNA Technology for medical breakthroughs
- Cost consideration for scale-up
- Using Microfluidizer¢ç processors in manufacturing for global commercial distribution |
|
|
|